Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
David Z Qian, Yukihiko Kato, Shabana Shabbeer, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
Understanding the development of enzalutamide resistance based on a functional single-cell approach
Changhui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Molecular Cancer Therapeutics
|
January 24, 2007
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma
Yukihiko Kato, Brenda C Salumbides, Xiao-Fei Wang, et al.
Scientific Reports
|
October 4, 2016
Systemic Inhibition of CREB is Well-tolerated in vivo
Bingbing X Li, Ryan Gardner, Changhui Xue, et al.
Journal of Cellular Biochemistry
|
February 1, 2018
microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1
Xiaowei Chen, Min Zhao, Jin Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma
Xiao-Fei Wang, David Z Qian, Mingqiang Ren, et al.
The Prostate
|
September 7, 2006
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer
John T Isaacs, Roberto Pili, David Z Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model
Henk M W Verheul, Hans Hammers, Karen van Erp, et al.
Plos One
|
September 6, 2007
The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin
Sushant K Kachhap, Dennis Faith, David Z Qian, et al.
Frontiers in Cell and Developmental Biology
|
November 25, 2021
HIF1 and ID1 Interplay Confers Adaptive Survival to HIF1α-Inhibition
Hao Geng, Hyun-Kyung Ko, Janet Pittsenbarger, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
David Z Qian, Yukihiko Kato, Shabana Shabbeer, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
Understanding the development of enzalutamide resistance based on a functional single-cell approach
Changhui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Molecular Cancer Therapeutics
|
January 24, 2007
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma
Yukihiko Kato, Brenda C Salumbides, Xiao-Fei Wang, et al.
Scientific Reports
|
October 4, 2016
Systemic Inhibition of CREB is Well-tolerated in vivo
Bingbing X Li, Ryan Gardner, Changhui Xue, et al.
Journal of Cellular Biochemistry
|
February 1, 2018
microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1
Xiaowei Chen, Min Zhao, Jin Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma
Xiao-Fei Wang, David Z Qian, Mingqiang Ren, et al.
The Prostate
|
September 7, 2006
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer
John T Isaacs, Roberto Pili, David Z Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model
Henk M W Verheul, Hans Hammers, Karen van Erp, et al.
Plos One
|
September 6, 2007
The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin
Sushant K Kachhap, Dennis Faith, David Z Qian, et al.
Frontiers in Cell and Developmental Biology
|
November 25, 2021
HIF1 and ID1 Interplay Confers Adaptive Survival to HIF1α-Inhibition
Hao Geng, Hyun-Kyung Ko, Janet Pittsenbarger, et al.
Page
of 5